Front Range CO
Pfizer to buy Boulder-based Array BioPharma in deal worth $11.4B
NEW YORK (AP) - Pfizer is delving deeper into cancer research with a roughly $11.4 billion deal for Array BioPharma, a drug developer that has seen its shares soar since announcing…
